Vasogen Inc - Report of Foreign Issuer (6-K)
10 Julho 2008 - 2:51PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE
ISSUER
Pursuant to Rule 13a-16 or
15d-16
Under the Securities Exchange Act of
1934
For
the month of July 2008
Commission
File Number: 0-29350
Vasogen
Inc.
(Translation
of registrant's name into English)
2505
Meadowvale Blvd, Mississauga, Ontario, L5N 5S2
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under
cover of Form 20-F or Form 40-F.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1). _____
Note:
Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K
if submitted solely to provide an attached annual report to security
holders.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7): _____
Note:
Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K
if submitted to furnish a report or other document that the registrant foreign
private issuer must furnish and make public under the laws of the jurisdiction
in which the registrant is incorporated, domiciled or legally organized (the
registrant's "home country"), or under the rules of the home country exchange on
which the registrant's securities are traded, as long as the report or other
document is not a press release, is not required to be and has not been
distributed to the registrant's security holders, and, if discussing a material
event, has already been the subject of a Form 6-K submission or other Commission
filing on EDGAR.
Indicate
by check mark whether the registrant by furnishing the information contained in
this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
If
"Yes" is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): 82-____________.
Consolidated
Financial Statements and Notes to Interim Financial Statements for the period
ended May 31, 2008 are attached as exhibit 99.1 to this report and are
incorporated herein by reference. Management’s Discussion and
Analysis for the period ended May 31, 2008 is attached as Exhibit 99.2 to this
report and is incorporated herein by reference. Forms 52-109, CEO/CFO
Certifications of Interim Filings, are attached as exhibit 99.3 to this report
and are incorporated herein by reference.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
VASOGEN
INC.
|
|
|
|
|
|
|
|
|
|
Date:
July 9, 2008
|
By:
|
/s/
Graham Neil
|
|
|
Name:
Graham Neil
|
|
|
Title:
Vice President, Finance and
|
EXHIBIT LIST
|
Exhibit
|
|
Description
|
|
|
|
|
|
99.1
|
|
Financial
Statements and Notes to Consolidated Financial Statements for the period
ended May 31, 2008
|
|
|
|
|
|
99.2
|
|
Management’s
Discussion and Analysis for the period ended May 31,
2008
|
|
|
|
|
|
99.3
|
|
Forms
52-109 CEO/CFO Certification of Interim
Filings
|
Vasogen (NASDAQ:VSGN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Vasogen (NASDAQ:VSGN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
